ANIK — Anika Therapeutics Share News
0.000.00%
Last trade - 00:00- $191.87m
- $150.85m
- $112.82m
Anika Therapeutics Inc expected to post earnings of 5 cents a share - Earnings Preview
Brief: Anika Therapeutics Says Integrity Implant System Is Now In Full Market Release And Broadly Available Across U.S
Brief: Anika Enters Into Cooperation Agreement With Caligan Partners
VSE Corp slips on pricing $150 mln stock offering
U.S. RESEARCH ROUNDUP- Corpay, Epam Systems, MKS Instruments
Brief: Anika Announces CFO Transition
Brief: Anika Therapeutics Q1 Revenue USD 40.523 Million
Anika Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Anika Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Anika Therapeutics Q4 Revenue USD 42.971 Million
Anika Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Activist investor Caligan discloses 9.7% stake in Anika, nominates two director candidates
Brief: Jeffery Thompson Notifies Anika Therapeutics Of Intention To Retire
Anika Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Anika Therapeutics Q3 Revenue USD 41.465 Million
Anika Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Anika Receives 510(K) Clearance For Integrity Implant System, A Regenerative Hyaluronic Acid-Based Patch System For Augmentation Of Rotator Cuff Repairs
Anika Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Anika Therapeutics Q2 Revenue USD 44.302 Million